Milbetab 12.5 mg/125 mg Tablets for Dogs
Milbetab 12.5 mg/125 mg Tablets for Dogs
Authorised
- Milbemycin oxime
- Praziquantel
Product identification
Medicine name:
Milbetab 12.5 mg/125 mg Tablets for Dogs
Milbetab, 12,5 mg/125 mg, tableta za pse
Active substance:
- Milbemycin oxime
- Praziquantel
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Milbemycin oxime12.50/milligram(s)1.00Tablet
-
Praziquantel125.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP54AB51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Croatia
Package description:
- Blister packs made up of a cold form laminate of OPA/ALU/PVC and a 20µm hard temper aluminium foil. Multipack of 10 individual packs of 50 tablets.
- Blister packs made up of a cold form laminate of OPA/ALU/PVC and a 20µm hard temper aluminium foil. Multipack of 10 individual packs of 20 tablets.
- Blister packs made up of a cold form laminate of OPA/ALU/PVC and a 20µm hard temper aluminium foil. Multipack of 10 individual packs of 2 tablets.
- Blister packs made up of a cold form laminate of OPA/ALU/PVC and a 20µm hard temper aluminium foil.Cardboard box with 500 tablets (50 blister strips of 10).
- Blister packs made up of a cold form laminate of OPA/ALU/PVC and a 20µm hard temper aluminium foil.Cardboard box with 200 (20 blister strips of 10)
- Blister packs made up of a cold form laminate of OPA/ALU/PVC and a 20µm hard temper aluminium foil.Cardboard box with 100 (10 blister strips of 10)
- Blister packs made up of a cold form laminate of OPA/ALU/PVC and a 20µm hard temper aluminium foil.Cardboard box with 50 (5 blister strips of 10)
- Blister packs made up of a cold form laminate of OPA/ALU/PVC and a 20µm hard temper aluminium foil.Cardboard box with 30 (3 blister strips of 10)
- Blister packs made up of a cold form laminate of OPA/ALU/PVC and a 20µm hard temper aluminium foil.Cardboard box with 20 (2 blister strips of 10)
- Blister packs made up of a cold form laminate of OPA/ALU/PVC and a 20µm hard temper aluminium foil.Cardboard box with 20 (10 blister strips of 2)
- Blister packs made up of a cold form laminate of OPA/ALU/PVC and a 20µm hard temper aluminium foil.Cardboard box with 10 (1 blister strip of 10)
- Blister packs made up of a cold form laminate of OPA/ALU/PVC and a 20µm hard temper aluminium foil.Cardboard box with 8 (4 blister strips of 2)
- Blister packs made up of a cold form laminate of OPA/ALU/PVC and a 20µm hard temper aluminium foil.Cardboard box with 8 (2 blister strips of 4)
- Blister packs made up of a cold form laminate of OPA/ALU/PVC and a 20µm hard temper aluminium foil.Cardboard box with 8 (1 blister strip of 8)
- Blister packs made up of a cold form laminate of OPA/ALU/PVC and a 20µm hard temper aluminium foil.Cardboard box with 4 (2 blister strips of 2)
- Blister packs made up of a cold form laminate of OPA/ALU/PVC and a 20µm hard temper aluminium foil.Cardboard box with 4 (1 blister strip of 4)
- Blister packs made up of a cold form laminate of OPA/ALU/PVC and a 20µm hard temper aluminium foil.Cardboard box with 2 (1 blister strip of 2)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
- Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
- UP/I-322-05/17-01/541
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0399/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Italy
-
Latvia
-
Luxembourg
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Slovakia
-
Spain
-
Sweden
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet